Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | TACR1 | P25103 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | P4HB | P07237 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1668486 | 0.91 | SMN1; SMN2 (0.43) | CYP2D6TACR1CHRM5CHRM1CHRM3 | |
| SCHEMBL12801191 | 0.89 | CHRM5 (0.46) | CHRM5CHRM1CHRM3APPRXRA | |
| SCHEMBL1668325 | 0.87 | OPRM1 (0.42) | CHRM5CHRM1CHRM3APPRXRA | |
| SCHEMBL1668281 | 0.85 | CHRM5 (0.39) | CHRM5CHRM1CHRM3OPRM1OPRD1 | |
| SCHEMBL12800426 | 0.84 | CYP2D6 (0.37) | CYP2D6TACR1CHRM5CHRM1CHRM3 | |
| SCHEMBL12800404 | 0.84 | CHRM5 (0.40) | CHRM5CHRM1CHRM3APPRXRA | |
| SCHEMBL1668720 | 0.83 | CHRM5 (0.43) | CHRM5CHRM1CHRM3RXRAOPRM1 | |
| SCHEMBL1668756 | 0.83 | OPRD1 (0.48) | TACR1OPRM1OPRD1OPRK1 | |
| SCHEMBL12800418 | 0.83 | OPRM1 (0.40) | TACR1APPRXRAOPRM1 | |
| SCHEMBL16499375 | 0.82 | CYP2D6 (0.56) | CYP2D6TACR1SMN1; SMN2OPRM1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011048409-A1 | CYCLIC AMINE DERIVATIVES HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY | ASTRAZENECA AB (SE) | 2011-04-28 | — | — | WO | disclosed |
| WO-2011048409-A1 | CYCLIC AMINE DERIVATIVES HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY | ASTRAZENECA AB (SE) | 2011-04-28 | — | — | WO | disclosed |